T
Tessera Therapeutics is a biotechnology company pioneering a new approach to genome engineering through the development of its Gene Writing™ and delivery platforms, with the aim to unlock broad new therapeutic frontiers. Our mission is to cure disease by writing in the code of life. We believe our Gene Writing™ and delivery platforms will enable transformative genetic medicines to treat monogenic diseases, cancer and potentially autoimmune and other diseases. Discover your future at Tessera.
Investor insights
Funding rounds participated in
$50M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Funding rounds raised
Total raised
$50M
from 1 investors over 1 rounds
T
Tessera Therapeutics raised $50M on January 18, 2025
Investors: Bill & Melinda Gates Foundation